XML 23 R7.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net income (loss) $ (52,528) $ 975
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 13,048 623
Bad debt expense 357 0
Amortization of debt discount and issuance costs 277 0
Share-based compensation expense 8,842 2,844
Change in fair value of earn-out liabilities 0 33,369
Change in fair value of warrant liabilities 9,422 (43,002)
Change in fair value of contingent consideration liabilities 521 0
Other (1,927) 194
Changes in operating assets and liabilities:    
Inventory, net (1,726) 0
Contract assets (12,642) 13,077
Prepaid expenses (17,685) (1,576)
Orbital receivables, net 7,689 0
Other assets, net 3,012 547
Accounts payable and accrued expenses 26,483 5,856
Accounts payable – affiliated companies 682 1,789
Contract liabilities – current and long-term (17,119) (8,626)
Securitization liabilities (2,692) 0
Pension and other postretirement benefits (2,763) 0
Other liabilities (17,294) (2,069)
Net cash provided by (used in) operating activities (54,768) 19,419
Cash flows from investing activities:    
Purchase of property and equipment (9,876) (6,122)
Purchase of intangible assets (444,779) 0
Net cash used in investing activities (454,655) (6,122)
Cash flows from financing activities:    
Warrants exercised 0 176,620
Redemption of warrants 0 (66)
Transaction costs related to the issuance of securities (7,550) 0
Repurchase of Class A Common Stock 0 (20,700)
Proceeds from issuance of securities 175,000 0
Payment of withholding taxes from share-based awards (1) (3,505)
Net cash provided by financing activities 167,449 152,349
Net increase (decrease) in cash, cash equivalents and restricted cash (341,974) 165,646
Cash, cash equivalents and restricted cash at beginning of the period 585,339 209,649
Cash, cash equivalents and restricted cash at end of the period 243,365 375,295
Less: restricted cash 11,741 2,042
Cash and cash equivalents 231,624 373,253
Supplemental disclosure of cash flow information    
Cash paid for interest 23 0
Cash paid for taxes 70 66
Accrued capital expenditures 10,092 930
Noncash investing and financing activities    
Class A Common Stock issued in acquisition, at fair value 403,952 0
Issuance of Class C Common Stock related to earn-out awards (Note 16) 0 167,525
Preferred dividends (162) (147)
Nonrelated Party    
Changes in operating assets and liabilities:    
Trade and other receivables, net $ 1,275 $ 15,418